Epsilon-poly-l-lysine microneedle patch loaded with amorphous doxycycline nanoparticles for synergistic treatment of skin infection

Int J Biol Macromol. 2024 May;266(Pt 2):131383. doi: 10.1016/j.ijbiomac.2024.131383. Epub 2024 Apr 4.

Abstract

The development of antibiotic-loaded microneedles has been hindered for years by limited excipient options, restricted drug-loading space, poor microneedle formability, and short-term drug retention. Therefore, this study proposes a dissolving microneedle fabricated from the host-defense peptide ε-poly-l-lysine (EPL) as an antibacterial adjuvant system for delivering antibiotics. EPL serves not only as a major matrix material for the microneedle tips, but also as a broad-spectrum antibacterial agent that facilitates the intracellular accumulation of the antibiotic doxycycline (DOX) by increasing bacterial cell membrane permeability. Furthermore, the formation of physically crosslinked networks of EPL affords microneedle tips with improved formability, good mechanical properties, and amorphous nanoparticles (approximately 7.2 nm) of encapsulated DOX. As a result, a high total loading content of both antimicrobials up to 2319.1 μg/patch is achieved for efficient transdermal drug delivery. In a Pseudomonas aeruginosa-induced deep cutaneous infection model, the EPL microneedles demonstrates potent and long-term effects by synergistically enhancing antibiotic activities and prolonging drug retention in infected lesions, resulting in remarkable therapeutic efficacy with 99.91 % (3.04 log) reduction in skin bacterial burden after a single administration. Overall, our study highlights the distinct advantages of EPL microneedles and their potential in clinical antibacterial practice when loaded with amorphous DOX nanoparticles.

Keywords: Amorphous nanoparticles; Antibacterial adjuvant system; Epsilon-poly-l-lysine microneedle.

MeSH terms

  • Administration, Cutaneous
  • Animals
  • Anti-Bacterial Agents* / administration & dosage
  • Anti-Bacterial Agents* / chemistry
  • Anti-Bacterial Agents* / pharmacology
  • Doxycycline* / administration & dosage
  • Doxycycline* / chemistry
  • Doxycycline* / pharmacology
  • Drug Delivery Systems
  • Mice
  • Nanoparticles* / chemistry
  • Needles*
  • Polylysine* / chemistry
  • Pseudomonas Infections / drug therapy
  • Pseudomonas aeruginosa / drug effects
  • Skin / drug effects
  • Skin / microbiology

Substances

  • Polylysine
  • Doxycycline
  • Anti-Bacterial Agents